Vytrus Biotech, S.A.

VYT

ES0105618005

Environmental Services & Equipment

Market Closed - BME Other stock markets 10:00:19 2024-05-10 EDT			5-day change	1st Jan Change
2.28 ^EUR	-5.00%		-3.39%	+22.58%

04-03	Vytrus Biotech, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Vytrus Biotech, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Phyture Biotech S.L. announced that it has received €0.61 million in funding from 1nKemia IUCT Group, S.A.

October 28, 2017

On October 29, 2017, Phyture Biotech S.L. closed the transaction. The company has raised €191,804 in its second tranche. The company has raised more than €604,304 in the transaction.

The transaction was oversubscribed.

Latest news about Vytrus Biotech, S.A.

Vytrus Biotech, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	04-03	CI
Vytrus Biotech, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-20	CI
Vytrus Biotech, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-28	CI
Vytrus Biotech, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-10-20	CI
Vytrus Biotech, S.A. commences an Equity Buyback Plan under the authorization approved on June 30, 2021.	22-05-12	CI
Vytrus Biotech, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-24	CI
Phyture Biotech S.L. announced that it has received €0.61 million in funding from 1nKemia IUCT Group, S.A.	17-10-28	CI
Phyture Biotech S.L. announced that it expects to receive €0.55 million in funding from 1nKemia IUCT Group, S.A.	17-07-29	CI

Vytrus Biotech SA, formerly Phyture Biotech SL, is Spain-based company principally engaged in the biotechnology industry. The Company develops high added value natural active ingredients on an industrial scale and provides ingredients and recombinant proteins for its use in the cosmetics and pharmaceutical sectors. The Companyâs technology is based on using plant cell cultures to produce bioactive molecules. The Company obtains plant cells, known as Plant Stem Cell technology, which is applicable for cosmetics. Vytrus Biotech specifically target dermo-cosmetics as well as veterinary medicine, functional food and other pharmaceuticals, generating savings of more than 99% in natural resources.

Sector

Environmental Services & Equipment

More about the company